134 related articles for article (PubMed ID: 25762609)
1. [Development of noninvasive bladder cancer diagnosis on basis of telomerase and it's subunits hTERT and hTR detection].
Glukhov AI; Grigorieva YE; Gordeev SA; Vinarov AZ; Potoldykova NV
Biomed Khim; 2015; 61(1):150-60. PubMed ID: 25762609
[TBL] [Abstract][Full Text] [Related]
2. Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer.
Weikert S; Krause H; Wolff I; Christoph F; Schrader M; Emrich T; Miller K; Müller M
Int J Cancer; 2005 Nov; 117(2):274-80. PubMed ID: 15900578
[TBL] [Abstract][Full Text] [Related]
3. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
Bialkowska-Hobrzanska H; Bowles L; Bukala B; Joseph MG; Fletcher R; Razvi H
Mol Diagn; 2000 Dec; 5(4):267-77. PubMed ID: 11172490
[TBL] [Abstract][Full Text] [Related]
4. [The role of telomerase activity in non-invasive diagnostics of bladder cancer].
Glybochko PV; Alyaev JG; Potoldykova NV; Polyakovsky KA; Vinarov AZ; Glukhov AI; Gordeev SA
Urologiia; 2016 Aug; (4):76-81. PubMed ID: 28247730
[TBL] [Abstract][Full Text] [Related]
5. Relevance of urine telomerase in the diagnosis of bladder cancer.
Sanchini MA; Gunelli R; Nanni O; Bravaccini S; Fabbri C; Sermasi A; Bercovich E; Ravaioli A; Amadori D; Calistri D
JAMA; 2005 Oct; 294(16):2052-6. PubMed ID: 16249419
[TBL] [Abstract][Full Text] [Related]
6. Urine telomerase: an important marker in the diagnosis of bladder cancer.
Sanchini MA; Bravaccini S; Medri L; Gunelli R; Nanni O; Monti F; Baccarani PC; Ravaioli A; Bercovich E; Amadori D; Calistri D
Neoplasia; 2004; 6(3):234-9. PubMed ID: 15153335
[TBL] [Abstract][Full Text] [Related]
7. Detection of telomerase status by semiquantitative and in situ assays, and by real-time reverse transcription-polymerase chain reaction (telomerase reverse transcriptase) assay in bladder carcinomas.
Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
BJU Int; 2003 Apr; 91(6):567-72. PubMed ID: 12656916
[TBL] [Abstract][Full Text] [Related]
8. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas].
Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058
[TBL] [Abstract][Full Text] [Related]
9. Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer.
Müller M; Krause H; Heicappell R; Tischendorf J; Shay JW; Miller K
Clin Cancer Res; 1998 Aug; 4(8):1949-54. PubMed ID: 9717824
[TBL] [Abstract][Full Text] [Related]
10. hTERT, hTR and TERT promoter mutations as markers for urological cancers detection: A systematic review.
Morozov A; Potoldykova N; Chinenov D; Enikeev M; Glukhov A; Shpikina A; Goryacheva E; Taratkin M; Malavaud B; Enikeev D
Urol Oncol; 2021 Aug; 39(8):498.e21-498.e33. PubMed ID: 33676848
[TBL] [Abstract][Full Text] [Related]
11. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
[TBL] [Abstract][Full Text] [Related]
12. Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker.
Melissourgos N; Kastrinakis NG; Davilas I; Foukas P; Farmakis A; Lykourinas M
Urology; 2003 Aug; 62(2):362-7. PubMed ID: 12893365
[TBL] [Abstract][Full Text] [Related]
13. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
14. Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts.
Brems-Eskildsen AS; Zieger K; Toldbod H; Holcomb C; Higuchi R; Mansilla F; Munksgaard PP; Borre M; Ørntoft TF; Dyrskjøt L
BMC Cancer; 2010 Nov; 10():646. PubMed ID: 21106093
[TBL] [Abstract][Full Text] [Related]
15. [Effects of combining siRNA-TR and TERT upon telomerase activity and in vitro growth inhibition in transitional cancer of bladder BIU-87 cell line].
Cheng W; Su Y; Ma HQ; Wei ZF; Gao JP; Zhang ZY; Ge JP; Jing KZ; Xu F
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2847-52. PubMed ID: 20137667
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection.
Neves M; Ciofu C; Larousserie F; Fleury J; Sibony M; Flahault A; Soubrier F; Gattegno B
J Urol; 2002 Mar; 167(3):1276-81. PubMed ID: 11832713
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer.
Dettlaff-Pokora A; Matuszewski M; Schlichtholz B
Cancer Lett; 2005 May; 222(1):83-8. PubMed ID: 15837544
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer.
Landman J; Chang Y; Kavaler E; Droller MJ; Liu BC
Urology; 1998 Sep; 52(3):398-402. PubMed ID: 9730450
[TBL] [Abstract][Full Text] [Related]
19. Expression and biological-clinical significance of hTR, hTERT and CKS2 in washing fluids of patients with bladder cancer.
Mezzasoma L; Antognelli C; Del Buono C; Stracci F; Cottini E; Cochetti G; Talesa VN; Mearini E
BMC Urol; 2010 Oct; 10():17. PubMed ID: 20920335
[TBL] [Abstract][Full Text] [Related]
20. Telomerase: its clinical relevance in the diagnosis of bladder cancer.
Müller M
Oncogene; 2002 Jan; 21(4):650-5. PubMed ID: 11850792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
